Healthcare
DocGo Inc.(DCGO)
Live Price
Offline$0.524
-7.42% today
1Y Change
-67.65%
Window
Jun 25, 2025 โ Jun 18, 2026
- Market Cap
- $70.00M
- Revenue Growth
- -47.7%
- EPS Growth
- -1020.0%
- Dividend Yield
- 0.0%
Coverage: 247 bars ยท Jun 25, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
DocGo Inc. (DCGO) is a Healthcare stock with a market cap of $70.00M and listed on NASDAQ. The stock last traded around $0.52 and down 67.7% across the available one-year price window (Jun 25, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of -47.7%, EPS growth of -1020.0%, a dividend yield of 0.0%. What stands out right now is revenue -47.7%, EPS -1020.0%, free cash flow -58.1% with operating margin -32.9% and ROIC -66.3%. Valuation is more restrained than many high-expectation growth names at price/sales 0.2. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines DCGO price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-47.7% vs +7.6% peer median
Operating Margin
Below sector median
-32.9% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 14, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -47.7% and EPS is at -1020.0%, with operating margin around -32.9%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -2.5% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 14, 2026 | โ | -3.4% | +1.9% | -1.9% |
2026 Mar 16, 2026 | -430.0% | +20.1% | +4.0% | -16.8% |
2025 Nov 10, 2025 | +26.2% | -0.9% | -13.2% | -10.4% |
Benchmark Edge
DCGO vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
DCGO
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
DCGO Max Drawdown
-69.94%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for DCGO and SPY.
Company Overview
DocGo Inc.
NASDAQ
DocGo Inc. is a dynamic healthcare service provider that focuses on mobile and integrated medical care solutions. The company operates by delivering non-emergency medical services directly to patients, breaking traditional barriers to healthcare access. A key feature of DocGo's business is its use of technology to streamline healthcare delivery, including real-time tracking of medical transportation and remote patient monitoring. This approach not only enhances patient convenience but also optimizes the efficiency of medical service delivery. DocGo's services are critical across various sectors, particularly in underserved communities where access to timely medical care is challenging. As an essential player in the healthcare sector, DocGo supports hospital systems and emergency services by alleviating the burden on traditional healthcare facilities, thereby contributing to the overall enhancement of healthcare infrastructure. Through its innovative model, DocGo is making significant strides in transforming healthcare accessibility and service delivery in the modern era.
- Leadership
- Mr. Lee Bienstock
- Employees
- 2.5k
- Street Address
- 685 Third Avenue, Suite 900, 9th Floor
- Mailing
- New York, NY, 10017
- Region
- New York, NY, United States
- Last Updated
- May 15, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 0.2
- Price/Book
- 0.5
Growth
- Revenue
- -47.7%
- EPS
- -1020.0%
- Free Cash Flow
- -58.1%
Profitability
- Gross Margin
- 30.7%
- Operating Margin
- -32.9%
- Net Margin
- -56.6%
- ROE
- -71.4%
- ROIC
- -66.3%
Balance Sheet
- Debt/Equity
- 0.20
- Current Ratio
- 2.26
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.